News
The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.
Toxoplasma gondii is a widespread parasite responsible for toxoplasmosis, an infection that often lacks clear symptoms but ...
Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.
Biogen has announced that it has initiated a phase 3 study of investigational felzartamab in adults with primary membranous ...
9d
Zacks.com on MSNBiogen Begins Phase III Felzartamab Study for Third Kidney DiseaseBIIB begins phase III dosing of felzartamab primary membranous nephropathy study, targeting a tough-to-treat condition with ...
The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous ...
SAN FRANCISCO and VANCOUVER, British Columbia, July 01, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: ...
9d
Pharmaceutical Technology on MSNFDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiencyThe FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...
This new article explores some of the possible reasons behind gluten sensitivity, such as various allergens and infections.
A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...
The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results